| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5537327 | Vaccine | 2016 | 7 Pages |
Abstract
After a first steep decline in antibody levels in the first year after the booster, antibody levels slowly declined between one and three years post-booster. A routine MenC-TT booster vaccination for adolescents in the Netherlands will likely provide long-term individual protection and potentially reduce the risk of resurgence of MenC disease in the general population.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Mariëtte B. van Ravenhorst, Axel Bonacic Marinovic, Fiona R.M. van der Klis, Debbie M. van Rooijen, Marjan van Maurik, Susanne P. Stoof, Elisabeth A.M. Sanders, Guy A.M. Berbers,